Lerma v. Schiff Nutrition International, Inc.
Case Number:
3:11-cv-01056
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Boodell & Domanskis
- Denlea & Carton
- Fitzgerald Knaier
- Latham & Watkins
- Levin Sedran
- Procopio Cory
- Weltman Law
Companies
Sectors & Industries:
-
March 27, 2015
Glucosamine Class Can't Back Out Of $5M Deal, Judge Says
A California magistrate refused Thursday to allow plaintiffs suing Schiff Nutrition International Inc. for allegedly deceptively marketing its glucosamine supplement as an arthritis treatment to back out of their proposed $5 million deal, saying "possible" objections and a recent Seventh Circuit decision don't justify their request.
-
February 24, 2015
Schiff Says Glucosamine Class Can't Flake On $5M Deal
Schiff Nutrition International Inc. on Monday urged a California federal judge not to let plaintiffs back out on a $5 million class settlement over claims that it falsely marketed a glucosamine dietary supplement as an arthritis treatment, arguing that the Seventh Circuit's criticism of a different settlement over a similar product doesn't apply to this case.
-
February 03, 2015
Schiff Nutrition Foes Can't Halt $5M Pact's Approval Process
A California federal magistrate on Monday nixed a request by plaintiffs to stay the approval process for a $5 million settlement in a class action accusing Schiff Nutrition International Inc. of falsely marketing its flagship dietary supplement as an arthritis treatment, saying a Seventh Circuit decision to overturn a different settlement didn't affect this case.
-
March 26, 2014
Schiff Nutrition Pays $5M In Dietary Supplement Labeling Row
Schiff Nutrition International Inc. has agreed to pay at least $5 million to settle a proposed class action accusing the company of falsely marketing its flagship dietary supplement as an arthritis treatment, according to a Tuesday filing in California federal court.
-
May 17, 2011
Schiff Nutrition Sued Over Dietary Supplement Claims
A California consumer hit Schiff Nutrition International Inc. with a class action Friday, accusing the company of falsely marketing its flagship dietary supplement as an arthritis treatment despite lacking any scientific evidence supporting its claims.